News

Researchers have identified bacteria from a New Jersey wetland that, surprisingly, can break carbon-fluorine bonds and degrade PFAS.

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives – signalling a new era of precision medicine for young patients.

Cold Spring Harbor Laboratory (CSHL) Professor Zach Lippman, a Howard Hughes Medical Institute investigator, recently teamed up with Yuval Eshed, an expert in plant development at the Weizmann Institute of Science in Israel, to sum up the current and future states of plant science and agriculture.

New RNA sequencing-based genetic research conducted at Washington State University's Bear Research, Education, and Conservation Center shows grizzlies express a larger number of genes in preparation for, and during hibernation to cope with such stressors, than do any other species studied.

Babies born vaginally have different gut bacteria - their microbiome - than those delivered by Caesarean, research has shown.

A research study shows evidence to demonstrate that life’s process on Earth could have actually started with molecules that looked like a mixture of RNA and DNA.

Creating mutations in a key Ebola virus protein that helps the deadly virus escape from the body's defenses can make the virus unable to produce sickness and activate protective immunity in the infected host, according to a study by the Institute for Biomedical Sciences at Georgia State University.

CRISPR technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros and cons in a review article in the journal Trends in Cell Biology.

In a study published today in GigaScience, the Penguin Genome Consortium has produced 19 high-coverage penguin genome sequences. Coupled with two previously published genomes, these sequences encompass all surviving penguin species.

Researchers at the University of Missouri School of Medicine have shown in a mouse study that the powerful gene editing technique known as CRISPR may provide the means for lifelong correction of the genetic mutation responsible for Duchenne muscular dystrophy.